As a member of the Chugai Group, Chugai Pharma U.S.A., LLC (CPUSA), founded in 1995 in San Diego, CA and currently based in Berkeley Heights, NJ, is committed to the timely development of safe and effective drugs for the North American market place. For more than 80 years our parent company, Chugai Pharmaceutical Co., Ltd. (Chugai), has provided high quality, safe and effective drugs to the Japanese & global market place. This is a heritage that will be continued in North America by CPUSA. As a result of the strategic global alliance between Chugai and F. Hoffmann-La Roche Ltd. in 2002, CPUSA is able to enjoy the resources of a large global conglomerate while preserving its autonomy as a Chugai Group company, the focus on products originated from Chugai research and agility of a small local company. CPUSA maintains the same therapeutic targets as the Japan parent does. We are currently working on treatments for cancer and cardiovascular disease. CPUSA is a company of collaborative, committed, talented and experienced people with an unwavering dedication to quality and the highest environmental and ethical standards. We all take great pride in bringing new medicines to market for the benefit of those in need.
